Not all KU technology is as big a commercial success as Abilify®, but it’s a great example of how innovation, research and protecting intellectual property are helping society and funding further research at KU.
TerraMetrics Agriculture, Inc. is affiliated with the University of Kansas Applied Remote Sensing (KARS) Program and the Kansas Biological Survey (KBS), incorporating 30 years of agricultural and natural resource research and product development experience. KARS and KBS are responsible for maintaining TMAI's leading edge in research and commercial product development. TMAI scientists and consultants work hand-in-hand with KARS Program scientists. The KARS Program is the home of the NASA Great Plains Regional Earth Science Applications Center (Great Plains RESAC), one of only seven NASA centers for excellence in the United States selected in a national competition, and the only NASA center dedicated to large-scale agricultural remote sensing research.
TVAX Biomedical, LLC was formed to commercialize a novel immunologic approach to cancer treatment. TVAX's personalized cancer treatment, TVAX Immunotherapy, used the natural resources of the cancer patient's own immune system to generate cancer specific killer T cells. Killer T cells that are delivered into the bloodstream of individuals with cancer will enter cancer tissue, kill cancer cells and reject growing cancers.
XenoTech, LLC was formed to manufacture products and to provide services to guide the discovery and development of drugs and other consumable products, such as food additives, fragrances, and cosmetics. XenoTech specializes in the development and application of in vitro techniques for examining the metabolism of drugs and other chemicals for pharmaceutical firms, chemical companies, academic institutions, and regulatory agencies, such as the United States Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA). XenoTech ’s products and services are designed to provide pre-clinical safety information of the type recommended by the FDA to predict inter-individual variability in drug safety and efficacy, and to predict or explain adverse drug-drug interactions.